Immunoxin

CAT-8015 · Cambridge Antibody Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immunoxin, covering 2007-08-14 to 2007-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease [Phase 1]